← Pharmacy curriculum

Cumulative review

Bring the systems together.

This review moves between mechanisms, monitoring, patient counseling, calculations, and clinical cases across all 8 modules and 37 submodules.

16 questionsDirect and case basedReasoning shown after submission
0 of 16 answered
01A new drug strongly inhibits the primary enzyme that clears a patient's existing medication. What is the most likely initial concern?
02What is the best next action?

A patient says they understand how to use a new injectable pen but cannot describe the preparation steps.

03Which issue may be preventing potassium correction?

A patient has persistent hypokalemia despite potassium replacement and also has a low magnesium concentration.

04Which cluster is most consistent with antimuscarinic effects?
05Which laboratory pair should receive prompt attention?

A patient taking a RAAS-inhibiting medicine develops weakness after a dose increase.

06What process is most concerning?

A patient with heart failure reports new ankle swelling, increasing weight, and difficulty breathing while lying flat.

07Why must the indication be confirmed before validating an anticoagulant dose?
08What medication review should occur first?

A hospitalized patient develops an abrupt rise in serum creatinine after several medication changes.

09What should be checked before automatically escalating therapy?

Asthma symptoms remain uncontrolled despite an apparently appropriate inhaler regimen.

10Which emergency is most consistent with this pattern?

A patient with diabetes presents with dehydration, ketones, and an anion-gap metabolic acidosis.

11Why can long-term systemic corticosteroid therapy require tapering?
12What is the best recommendation?

A patient seeking self-treatment for reflux reports progressively worsening difficulty swallowing.

13Which monitoring domain is especially important with many second-generation antipsychotics?
14What stewardship action should be considered?

Broad empiric antibiotics were started for severe infection. Cultures now identify a susceptible organism and the patient is improving.

15Which calculation is central to assessing neutropenia-related infection risk?

A patient receiving myelosuppressive cancer therapy develops fever.

16What is the immediate priority?

An unconscious patient arrives after an unknown ingestion with slow, shallow breathing.

Answer every question to submit.
PharmacyOpen tools